Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL

  • Cells. 2021 Oct 20;10(11):2803. doi: 10.3390/cells10112803.
Manuel Olazábal-Morán  1 Miriam Sánchez-Ortega  1 Laura Martínez-Muñoz  1 Carmen Hernández  1 Manuel S Rodríguez  2 Mario Mellado  1 Ana C Carrera  1
Affiliations
  • 1. Department of Immunology and Oncology, Centro Nacional de Biotecnología, CSIC-Campus Cantoblanco Autónoma University, 28049 Madrid, Spain.
  • 2. Institut des Technologies Avancées en Sciences du Vivant (ITAV), 1 Place Pierre Potier, Université de Toulouse, CNRS, UPS, 31000 Toulouse, France.
Abstract

3-Poly-phosphoinositides (PIP3) regulate cell survival, division, and migration. Both PI3-kinase (phosphoinositide-3-kinase) and PTEN (Phosphatase and tensin-homolog in chromosome 10) control PIP3 levels, but the mechanisms connecting PI3-kinase and PTEN are unknown. Using non-transformed cells, the activation kinetics of PTEN and of the PIP3-effector Akt were examined after the addition of growth factors. Both epidermal growth factor and serum induced the early activation of Akt and the simultaneous inactivation of PTEN (at ~5 min). This PIP3/Akt peak was followed by a general reduction in Akt activity coincident with the recovery of PTEN Phosphatase activity (at ~10-15 min). Subsequent Akt peaks and troughs followed. The fluctuation in Akt activity was linked to that of PTEN; PTEN reconstitution in PTEN-null cells restored Akt fluctuations, while PTEN depletion in control cells abrogated them. The analysis of PTEN activity fluctuations after the addition of growth factors showed its inactivation at ~5 min to be simultaneous with its transient ubiquitination, which was regulated by the ubiquitin E3 Ligase cCBL (casitas B-lineage lymphoma proto-oncogene). Protein-protein interaction analysis revealed cCBL to be brought into the proximity of PTEN in a PI3-kinase-dependent manner. These results reveal a mechanism for PI3-kinase/PTEN crosstalk and suggest that cCBL could be new target in strategies designed to modulate PTEN activity in Cancer.

Keywords
AKT; CBL; E3 ubiquitin ligase; PTEN; phosphatidylinositide 3-kinase.
Products